Essell JH - Search Results

1

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.

Shaughnessy PJ, Bachier C, Grimley M, Freytes CO, Callander NS, Essell JH, Flomenberg N, Selby G, Lemaistre CF. Shaughnessy PJ, et al. Among authors: essell jh. Biol Blood Marrow Transplant. 2005 Mar;11(3):188-93. doi: 10.1016/j.bbmt.2004.11.022. Biol Blood Marrow Transplant. 2005. PMID: 15744237 Free article. Clinical Trial.

2

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease.

Jagasia M, Lazaryan A, Bachier CR, Salhotra A, Weisdorf DJ, Zoghi B, Essell J, Green L, Schueller O, Patel J, Zanin-Zhorov A, Weiss JM, Yang Z, Eiznhamer D, Aggarwal SK, Blazar BR, Lee SJ. Jagasia M, et al. J Clin Oncol. 2021 Jun 10;39(17):1888-1898. doi: 10.1200/JCO.20.02754. Epub 2021 Apr 20. J Clin Oncol. 2021. PMID: 33877856 Free PMC article. Clinical Trial.

3

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients.

Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Callander NS, Clement DJ. Essell JH, et al. Bone Marrow Transplant. 1992 Oct;10(4):367-72. Bone Marrow Transplant. 1992. PMID: 1422493 Clinical Trial.

4

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.

Essell JH, Schroeder MT, Harman GS, Halvorson R, Lew V, Callander N, Snyder M, Lewis SK, Allerton JP, Thompson JM. Essell JH, et al. Ann Intern Med. 1998 Jun 15;128(12 Pt 1):975-81. doi: 10.7326/0003-4819-128-12_part_1-199806150-00002. Ann Intern Med. 1998. PMID: 9625683 Clinical Trial.

5

Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.

Horwitz ME, Spasojevic I, Morris A, Telen M, Essell J, Gasparetto C, Sullivan K, Long G, Chute J, Chao N, Rizzieri D. Horwitz ME, et al. Biol Blood Marrow Transplant. 2007 Dec;13(12):1422-6. doi: 10.1016/j.bbmt.2007.08.050. Biol Blood Marrow Transplant. 2007. PMID: 18022571 Free PMC article.

6

Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.

Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Johnson RA, Rubinsak JR. Essell JH, et al. Blood. 1992 May 15;79(10):2784-8. Blood. 1992. PMID: 1586725 Free article. Clinical Trial.

7

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass.

Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Essell JH, et al. J Cardiothorac Vasc Anesth. 1993 Aug;7(4):410-5. doi: 10.1016/1053-0770(93)90161-d. J Cardiothorac Vasc Anesth. 1993. PMID: 8400095

8

Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.

Niesvizky R, Flinn IW, Rifkin R, Gabrail N, Charu V, Clowney B, Essell J, Gaffar Y, Warr T, Neuwirth R, Zhu Y, Elliott J, Esseltine DL, Niculescu L, Reeves J. Niesvizky R, et al. J Clin Oncol. 2015 Nov 20;33(33):3921-9. doi: 10.1200/JCO.2014.58.7618. Epub 2015 Jun 8. J Clin Oncol. 2015. PMID: 26056177 Clinical Trial.

9

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study.

Burris HA 3rd, Flinn IW, Patel MR, Fenske TS, Deng C, Brander DM, Gutierrez M, Essell JH, Kuhn JG, Miskin HP, Sportelli P, Weiss MS, Vakkalanka S, Savona MR, O'Connor OA. Burris HA 3rd, et al. Among authors: essell jh. Lancet Oncol. 2018 Apr;19(4):486-496. doi: 10.1016/S1470-2045(18)30082-2. Epub 2018 Feb 20. Lancet Oncol. 2018. PMID: 29475723 Clinical Trial.

10

Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study.

Davids MS, Kuss BJ, Hillmen P, Montillo M, Moreno C, Essell J, Lamanna N, Nagy Z, Tam CS, Stilgenbauer S, Ghia P, Delgado J, Lustgarten S, Weaver DT, Youssoufian H, Jäger U. Davids MS, et al. Clin Cancer Res. 2020 May 1;26(9):2096-2103. doi: 10.1158/1078-0432.CCR-19-3061. Epub 2020 Jan 21. Clin Cancer Res. 2020. PMID: 31964785 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page